Diana Karpman

51 – 60 of 131

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/d1e6810c-2936-460f-a77a-e57a0295dd7a?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
5
6
7
8
…
14
next »

2013
Mark Complement activation in thrombotic microangiopathy.
Karpman, Diana ^LU and Tati, Ramesh ^LU (2013) In Hämostaseologie 33(2). p.96-104
- Contribution to journal › Scientific review
Mark Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab
Besbas, Nesrin ; Gulhan, Bora ; Karpman, Diana ^LU ; Topaloglu, Rezan ; Duzova, Ali ; Korkmaz, Emine and Ozaltin, Fatih (2013) In Pediatric Nephrology 28(1). p.155-158
- Contribution to journal › Article
Mark Complement Activation Associated with ADAMTS13 Deficiency in Human and Murine Thrombotic Microangiopathy.
Tati, Ramesh ^LU ; Kristoffersson, Ann-Charlotte ^LU ; Ståhl, Anne-lie ^LU ; Rebetz, Johan ^LU ; Wang, Li ; Licht, Christoph ; Motto, David and Karpman, Diana ^LU (2013) In Journal of Immunology 191(5). p.2184-2193
- Contribution to journal › Article
2012
Mark The Antimicrobial Peptide Cathelicidin Protects Mice from Escherichia coli O157:H7-Mediated Disease.
Chromek, Milan ^LU ; Arvidsson, Ida ^LU and Karpman, Diana ^LU (2012) In PLoS ONE 7(10).
- Contribution to journal › Article
Mark Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed
Karpman, Diana ^LU (2012) In Nephrology Dialysis Transplantation 27(10). p.3669-3674
- Contribution to journal › Debate/Note/Editorial
Mark Escherichia coli O104:H4 and Hemolytic Uremic Syndrome: The Analysis Begins
Tarr, Phillip I. and Karpman, Diana ^LU (2012) In Clinical Infectious Diseases 55(6). p.760-763
- Contribution to journal › Debate/Note/Editorial
Mark A Novel C3 Mutation Causing Increased Formation of the C3 Convertase in Familial Atypical Hemolytic Uremic Syndrome.
Sartz, Lisa ^LU ; Olin, Anders ^LU ; Kristoffersson, Ann-Charlotte ^LU ; Ståhl, Anne-lie ^LU ; Johansson, Martin E ; Westman, Kerstin ^LU ; Fremeaux-Bacchi, Veronique ; Nilsson, Kristina and Karpman, Diana ^LU (2012) In Journal of immunology 188(4). p.2030-2037
- Contribution to journal › Article
Mark Shiga toxin pathogenesis : kidney complications and renal failure
Obrig, Tom G and Karpman, Diana ^LU (2012) In Current Topics in Microbiology and Immunology 357. p.36-105
- Contribution to journal › Article
2011
Mark Kinin System Activation in Vasculitis.
Kahn, Robin ^LU and Karpman, Diana ^LU (2011) In Acta paediatrica 100(7). p.950-957
- Contribution to journal › Article
Mark Phenotypic Expression of ADAMTS13 in Glomerular Endothelial Cells
Tati, Ramesh ^LU ; Kristoffersson, Ann-Charlotte ^LU ; Ståhl, Anne-Lie ^LU ; Mörgelin, Matthias ^LU ; Motto, David ; Satchell, Simon ; Mathieson, Peter ; Manea Hedström, Minola ^LU and Karpman, Diana ^LU (2011) In PLoS ONE 6(6).
- Contribution to journal › Article

« previous
1
…
5
6
7
8
…
14
next »